| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(02)00004-1 |
| P698 | PubMed publication ID | 11943427 |
| P50 | author | Patrick Marcellin | Q89798262 |
| Dominique C Valla | Q41855926 | ||
| P2093 | author name string | Bach-Nga Pham | |
| Michelle Martinot-Peignoux | |||
| Corinne Castelnau | |||
| Nathalie Boyer | |||
| Claude Degott | |||
| Magalie Colombat | |||
| Rahouda Akremi | |||
| Stephan Ollivier | |||
| P2860 | cites work | Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B | Q73523464 |
| Histological grading and staging of chronic hepatitis | Q29619625 | ||
| Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease | Q32086267 | ||
| Hepatitis B infection: pathogenesis and management | Q33870241 | ||
| Management of hepatitis B: 2000--summary of a workshop | Q34263265 | ||
| Chronic type B hepatitis and the "healthy" HBsAg carrier state | Q39662797 | ||
| A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army | Q40797808 | ||
| A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. | Q43468968 | ||
| Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays | Q45743874 | ||
| Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. | Q45848781 | ||
| Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. | Q45858583 | ||
| Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B | Q61045644 | ||
| Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases | Q68960075 | ||
| The natural history of asymptomatic hepatitis B surface antigen carriers | Q70523365 | ||
| P433 | issue | 4 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| P304 | page(s) | 543-546 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers | |
| P478 | volume | 36 |
| Q40547583 | A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation |
| Q45710527 | A combined oligonucleotide and protein microarray for the codetection of nucleic acids and antibodies associated with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections |
| Q34184642 | A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. |
| Q35464781 | Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase |
| Q45367086 | Analysis of carriers of hepatitis B virus from a tertiary referral hospital: does the viral load change during the natural course of infection? |
| Q35054630 | Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study |
| Q30368428 | Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. |
| Q35621763 | Challenges in therapy of chronic hepatitis B. |
| Q59357694 | Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases |
| Q43418143 | Chronic HBV without e antigen: using HBV DNA to guide management |
| Q51018417 | Chronic HBV-infected subjects older than 35 years with persistently normal ALT and ultrasound, despite high viral load do not have significant fibrosis. |
| Q46959082 | Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study |
| Q58765488 | Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China |
| Q77908549 | Clinical utility in quantifying serum HBV DNA levels using PCR assays |
| Q35621629 | Clinical virology of hepatitis B virus infection |
| Q30358894 | Current role of transient elastography in the management of chronic hepatitis B patients |
| Q45414523 | Distribution of hepatitis B virus genotypes among patients with chronic infection |
| Q33801300 | Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy |
| Q45353649 | Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection |
| Q35073559 | Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study |
| Q40667034 | Fluctuation of Viremia in Hepatitis B Virus-Infected Healthcare Workers Performing Exposure-Prone Procedures in the Netherlands |
| Q38174257 | HBsAg quantification: useful for monitoring natural history and treatment outcome |
| Q50998161 | Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy? |
| Q45387029 | Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL. |
| Q35621634 | Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics |
| Q36346432 | Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers |
| Q30235028 | Hepatitis B virus and its sexually transmitted infection - an update |
| Q44329278 | Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection |
| Q45421390 | High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection |
| Q37339807 | High prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection. |
| Q37128478 | Histological grading and staging of liver and its relation to viral loads in chronic anti-HBe positive hepatitis |
| Q37631709 | How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level? |
| Q64994320 | Inactive hepatitis B carriers: outcomes of patients followed at Hôpital Principal de Dakar, Senegal. |
| Q42244740 | JSH Guidelines for the Management of Hepatitis B Virus Infection |
| Q36153966 | KASL Clinical Practice Guidelines: Management of chronic hepatitis B. |
| Q64897844 | KASL clinical practice guidelines for management of chronic hepatitis B. |
| Q26752475 | KASL clinical practice guidelines: management of chronic hepatitis B |
| Q40224069 | Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea |
| Q37462537 | Liver biopsy findings in chronic hepatitis B. |
| Q35621643 | Liver tissue examination |
| Q46045006 | Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time |
| Q45397821 | Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection |
| Q37241959 | Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers |
| Q35838778 | Management of hepatitis B during pregnancy |
| Q35635637 | Management of hepatitis B in developing countries |
| Q42256245 | Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers |
| Q33661037 | MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects |
| Q36881140 | Molecular testing in the diagnosis and management of chronic hepatitis B |
| Q38955049 | Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay. |
| Q40585285 | Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay |
| Q34157099 | Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis |
| Q39511336 | Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. |
| Q34768651 | Occult hepatitis B. |
| Q37590449 | Parameters associated with significant liver histological changes in patients with chronic hepatitis B. |
| Q39134670 | Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma. |
| Q42174350 | Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B. |
| Q33580037 | Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection |
| Q41824092 | Quantification of hepatitis B virus (HBV) DNA with a TaqMan HBV analyte-specific reagent following sample processing with the MagNA pure LC instrument |
| Q43428264 | Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease |
| Q44226733 | Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection |
| Q36177134 | Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010. |
| Q37136404 | Risk of hepatitis B infections in Olympic wrestling |
| Q37634822 | SASLT practice guidelines for the management of hepatitis B virus. |
| Q38953790 | Screening and diagnosis of HBV in low-income and middle-income countries |
| Q51368668 | Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion. |
| Q64107244 | Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection |
| Q35054972 | Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease |
| Q45401448 | Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection. |
| Q45077766 | Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B. |
| Q45710724 | Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection |
| Q35036631 | Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT |
| Q91209053 | Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses |
| Q80752603 | Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients |
| Q38175460 | Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis |
| Q39154229 | The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy |
| Q64132783 | The natural history of chronic hepatitis B virus infection |
| Q38685595 | The prognosis and management of inactive HBV carriers. |
| Q40699496 | The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study |
| Q42360905 | The role of HBsAg levels in the current management of chronic HBV infection |
| Q38071397 | The role of HBsAg quantification for monitoring natural history and treatment outcome |
| Q34173092 | Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B. |
| Q44967742 | Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. |
| Q35617319 | Viral hepatitis B. |
| Q80809737 | Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level |
| Q45461940 | Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study. |
| Q73331012 | What should be done about hepatitis-B-infected health-care workers? |
| Q81703409 | [Inactive carrier of hepatitis B virus] |
Search more.